Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AZD8359 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on AZD8359, a putative CD8-guided T-cell engager targeting STEAP2 (Apr 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AZD8359 | AZD 8359|AZD-8359 | Limited information is currently available on AZD8359, a putative CD8-guided T-cell engager targeting STEAP2 (Apr 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07529717 | Phase Ib/II | AZD8359 | First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer (CRIUS-1) | Not yet recruiting | USA | AUS | 1 |